Article ID Journal Published Year Pages File Type
10613038 Journal of Controlled Release 2012 7 Pages PDF
Abstract
The anticancer action and PK profile of Cellax (a nanoparticle formulation of docetaxel), were contrasted with Abraxane, an approved nanoparticle formulation of paclitaxel. Cellax exhibited particular advantages against metastatic breast cancer.80
Keywords
Related Topics
Physical Sciences and Engineering Materials Science Biomaterials
Preview
A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases
Authors
, , , , , ,